{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T16:47:13Z","timestamp":1768927633797,"version":"3.49.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.ajo.2013.01.014","type":"journal-article","created":{"date-parts":[[2013,3,12]],"date-time":"2013-03-12T19:33:16Z","timestamp":1363116796000},"page":"1119-1124.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":105,"title":["Intravitreal Bevacizumab for Retinopathy of Prematurity: Refractive Error Results"],"prefix":"10.1016","volume":"155","author":[{"given":"Bj\u00f6rn C.","family":"Harder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank C.","family":"Schlichtenbrede","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"von Baltz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waldemar","family":"Jendritza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bettina","family":"Jendritza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jost B.","family":"Jonas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ajo.2013.01.014_bib1","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/IAE.0b013e3181a3b848","article-title":"Concentration of vascular endothelial growth factor in aqueous humor of eyes with advanced retinopathy of prematurity before and after intravitreal injection of bevacizumab","volume":"29","author":"Nonobe","year":"2009","journal-title":"Retina"},{"issue":"9","key":"10.1016\/j.ajo.2013.01.014_bib2","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.ophtha.2008.12.023","article-title":"Vitreous levels of erythropoietin and vascular endothelial growth factor in eyes with retinopathy of prematurity","volume":"116","author":"Sato","year":"2009","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ajo.2013.01.014_bib3","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/IAE.0b013e318177f934","article-title":"Intravitreal injection of bevacizumab (Avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II","volume":"28","author":"Mintz-Hittner","year":"2008","journal-title":"Retina"},{"issue":"6","key":"10.1016\/j.ajo.2013.01.014_bib4","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1600-0420.2007.01106.x","article-title":"Intravitreal and intracameral bevacizumab to treat neovascular complications of retinopathy of prematurity","volume":"86","author":"dell'Omo","year":"2008","journal-title":"Acta Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajo.2013.01.014_bib5","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1136\/bjo.2008.140657","article-title":"Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: a pilot study","volume":"92","author":"Kusaka","year":"2008","journal-title":"Br J Ophthalmol"},{"issue":"3 Suppl","key":"10.1016\/j.ajo.2013.01.014_bib6","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1097\/IAE.0b013e3181644ad2","article-title":"Off-label use of intravitreal bevacizumab (Avastin) for salvage treatment in progressive threshold retinopathy of prematurity","volume":"28","author":"Lalwani","year":"2008","journal-title":"Retina"},{"issue":"3 Suppl","key":"10.1016\/j.ajo.2013.01.014_bib7","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1097\/IAE.0b013e318159ec6b","article-title":"Antiangiogenic therapy with intravitreal bevacizumab for retinopathy of prematurity","volume":"28","author":"Quiroz-Mercado","year":"2008","journal-title":"Retina"},{"issue":"4 Suppl","key":"10.1016\/j.ajo.2013.01.014_bib8","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1097\/IAE.0b013e3181ca1457","article-title":"Treatment of type 1 retinopathy of prematurity with intravitreal bevacizumab (Avastin)","volume":"30","author":"Dorta","year":"2010","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.ajo.2013.01.014_bib9","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ophtha.2010.04.018","article-title":"Effects and complications of bevacizumab use in patients with retinopathy of prematurity: a multicenter study in Taiwan","volume":"118","author":"Wu","year":"2011","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.ajo.2013.01.014_bib10","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1007374","article-title":"Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity","volume":"364","author":"Mintz-Hittner","year":"2011","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ajo.2013.01.014_bib11","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1001\/archophthalmol.2012.1","article-title":"Early refractive outcome after intravitreal bevazicumab for retinopathy of prematurity","volume":"130","author":"Harder","year":"2012","journal-title":"Arch Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2013.01.014_bib12","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archopht.123.7.991","article-title":"The International Classification of Retinopathy of Prematurity revisited","volume":"123","author":"International Committee for the Classification of Retinopathy of Prematurity","year":"2005","journal-title":"Arch Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2013.01.014_bib13","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/archopht.121.12.1684","article-title":"Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial","volume":"121","author":"Early Treatment for Retinopathy of Prematurity Cooperative Group","year":"2003","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2013.01.014_bib14","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0161-6420(01)01015-6","article-title":"A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years: part 2. Refractive outcome","volume":"109","author":"Connolly","year":"2002","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajo.2013.01.014_bib15","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S1091-8531(99)70008-X","article-title":"Therapeutic outcomes of cryotherapy versus transpupillary diode laser photocoagulation for threshold retinopathy of prematurity","volume":"3","author":"Paysse","year":"1999","journal-title":"J AAPOS"},{"issue":"9","key":"10.1016\/j.ajo.2013.01.014_bib16","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/0042-6989(94)00227-D","article-title":"The course of myopia in children with mild retinopathy of prematurity","volume":"35","author":"Lue","year":"1995","journal-title":"Vis Res"},{"issue":"9","key":"10.1016\/j.ajo.2013.01.014_bib17","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.ophtha.2005.03.025","article-title":"Prevalence of myopia at 9\u00a0months in infants with high-risk prethreshold retinopathy of prematurity","volume":"112","author":"Davitt","year":"2005","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2013.01.014_bib18","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0161-6420(00)00527-3","article-title":"Does cryotherapy affect refractive error? Results from treated versus control eyes in the Cryotherapy for Retinopathy of Prematurity trial","volume":"108","author":"Quinn","year":"2001","journal-title":"Ophthalmology"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939413000706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939413000706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:07:35Z","timestamp":1757596055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939413000706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0002939413000706"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2013.01.014","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravitreal Bevacizumab for Retinopathy of Prematurity: Refractive Error Results","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2013.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}